SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-016601
Filing Date
2019-11-07
Accepted
2019-11-07 13:07:56
Documents
63
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 659730
2 ex10-1.htm EX-10.1 32518
3 ex31-1.htm EX-31.1 20499
4 ex31-2.htm EX-31.2 20460
5 ex32-1.htm EX-32.1 7272
6 ex32-2.htm EX-32.2 8365
  Complete submission text file 0001493152-19-016601.txt   3698228

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE crbp-20190930.xml EX-101.INS 506306
8 XBRL SCHEMA FILE crbp-20190930.xsd EX-101.SCH 54252
9 XBRL CALCULATION FILE crbp-20190930_cal.xml EX-101.CAL 51571
10 XBRL DEFINITION FILE crbp-20190930_def.xml EX-101.DEF 174115
11 XBRL LABEL FILE crbp-20190930_lab.xml EX-101.LAB 355485
12 XBRL PRESENTATION FILE crbp-20190930_pre.xml EX-101.PRE 256800
Mailing Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37348 | Film No.: 191199411
SIC: 2834 Pharmaceutical Preparations